NexImmune, Inc. Common Stock
NEXI
NEXI was delisted on the 11th of July, 2024.
38 hedge funds and large institutions have $4.34M invested in NexImmune, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 12 closing their positions.
14% less funds holding
Funds holding: 44 → 38 (-6)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
67% less capital invested
Capital invested by funds: $13.4M → $4.34M (-$9.02M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KHCM
Kettle Hill Capital Management
New York
|
+$115K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31.7K |
| 3 |
Man Group
London,
United Kingdom
|
+$23.8K |
| 4 |
Renaissance Technologies
New York
|
+$14.9K |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
+$14.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$419K |
| 2 |
E
Ergoteles
New York
|
-$139K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$68K |
| 4 |
Goldman Sachs
New York
|
-$47K |
| 5 |
B
Bailard
Foster City,
California
|
-$33K |
NEXI Hedge Fund Activity: Q3 2022 in Review
38 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q3 2022, worth a combined $4.34M — down 67% from $13.4M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of NEXI and 6 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 6 added.
The largest buyer was Kettle Hill Capital Management, adding an estimated $115K. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $419K.
- 38 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q3 2022, down from 44 in Q2 2022.
- Funds reported $4.34M of NexImmune, Inc. Common Stock stock for Q3 2022, down 67% quarter-over-quarter.
- 6 funds opened new NexImmune, Inc. Common Stock positions in Q3 2022 and 12 closed out, a net change of -6 holders.
- The largest NexImmune, Inc. Common Stock buyer in Q3 2022 was Kettle Hill Capital Management, an estimated $115K added.
- The largest NexImmune, Inc. Common Stock seller in Q3 2022 was ArrowMark Colorado Holdings, an estimated $419K sold.
Based on aggregated 13F filings for Q3 2022.